An Ohio-based healthcare AI company focused on improving fiscal performance for payers as well as providers is buying a like-minded entity with expertise in streamlining prior-authorization processes.  

Some 501 accountable care organizations and other provider entities are urging Congressional leadership of both parties to modify the “unrealistic threshold tests” set out in the 2021 edition of the bipartisan Medicare Access and CHIP Reauthorization Act (MACRA) of 2015.

In some areas the business downturns may rival the low points of March and April, when the pandemic pummeled the healthcare economy.

The Pharmaceutical Research and Manufacturers of America (PhRMA) is combining forces with two other groups to challenge the FDA final rule allowing broad, state-by-state importation of drugs from Canada.

AI will only succeed in healthcare to the extent that it wins over all three stakeholder subpopulations—providers, payers and patients.

When Amazon opened the doors of its drugstore business Nov. 17, the potential competitive ramifications rattled that industry on many levels. Would establishment drug sellers stand a chance against the mighty retail innovator?

A new company called DeliverHealth Solutions is forming to service clients of Nuance’s HIM transcription and EHR go-live businesses.

COVID-19 has not so much rebooted U.S. healthcare’s workforce as it has hastened transformative changes in staffing strategies that were taking shape before the pandemic got here.